| Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. L Gaspar, C Scott, M Rotman, S Asbell, T Phillips, T Wasserman, ... International journal of radiation oncology, biology, physics 37 (4), 745-751, 1997 | 3126 | 1997 |
| Oxidative phosphorylation as an emerging target in cancer therapy TM Ashton, WG McKenna, LA Kunz-Schughart, GS Higgins Clinical Cancer Research 24 (11), 2482-2490, 2018 | 961 | 2018 |
| Review of clinical oncology MD Abeloff, JO Armitage, JE Niederhuber, MB Kastan, WG McKenna Churchill Livingstone, 02973-6, 2004 | 591 | 2004 |
| Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction AK Gupta, WG McKenna, CN Weber, MD Feldman, JD Goldsmith, R Mick, ... Clinical Cancer Research 8 (3), 885-892, 2002 | 479 | 2002 |
| Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation E Fokas, R Prevo, JR Pollard, PM Reaper, PA Charlton, B Cornelissen, ... Cell death & disease 3 (12), e441-e441, 2012 | 473 | 2012 |
| Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer TJ Robnett, M Machtay, EF Vines, MG McKenna, KM Algazy, ... International Journal of Radiation Oncology* Biology* Physics 48 (1), 89-94, 2000 | 441 | 2000 |
| How does radiation kill cells? E Cohen–Jonathan, EJ Bernhard, WG McKenna Current opinion in chemical biology 3 (1), 77-83, 1999 | 428 | 1999 |
| The molecular basis for cell cycle delays following ionizing radiation: a review A Maity, WG McKenna, RJ Muschel Radiotherapy and oncology 31 (1), 1-13, 1994 | 409 | 1994 |
| The Ras radiation resistance pathway AK Gupta, VJ Bakanauskas, GJ Cerniglia, Y Cheng, EJ Bernhard, ... Cancer research 61 (10), 4278-4282, 2001 | 337 | 2001 |
| Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth P Fei, W Wang, S Kim, S Wang, TF Burns, JK Sax, M Buzzai, DT Dicker, ... Cancer cell 6 (6), 597-609, 2004 | 285 | 2004 |
| Metalloprotease SPRTN/DVC1 orchestrates replication-coupled DNA-protein crosslink repair B Vaz, M Popovic, JA Newman, J Fielden, H Aitkenhead, S Halder, ... Molecular cell 64 (4), 704-719, 2016 | 278 | 2016 |
| The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy R Prevo, E Fokas, PM Reaper, PA Charlton, JR Pollard, WG McKenna, ... Cancer biology & therapy 13 (11), 1072-1081, 2012 | 278 | 2012 |
| Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002 AK Gupta, GJ Cerniglia, R Mick, MS Ahmed, VJ Bakanauskas, ... International Journal of Radiation Oncology* Biology* Physics 56 (3), 846-853, 2003 | 268 | 2003 |
| Inhibiting Ras Prenylation Increases the Radiosensitivity of Human Tumor Cell Lines with Activating Mutations of ras Oncogenes EJ Bernhard, WG McKenna, AD Hamilton, SM Sebti, Y Qian, J Wu, ... Cancer research 58 (8), 1754-1761, 1998 | 257 | 1998 |
| Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response GD Kao, WG McKenna, MG Guenther, RJ Muschel, MA Lazar, TJ Yen The Journal of cell biology 160 (7), 1017-1027, 2003 | 249 | 2003 |
| Detection of hypoxia in human squamous cell carcinoma by EF5 binding SM Evans, S Hahn, DR Pook, WT Jenkins, AA Chalian, P Zhang, ... Cancer research 60 (7), 2018-2024, 2000 | 245 | 2000 |
| Targeting ATR in DNA damage response and cancer therapeutics E Fokas, R Prevo, EM Hammond, TB Brunner, WG McKenna, RJ Muschel Cancer treatment reviews 40 (1), 109-117, 2014 | 244 | 2014 |
| Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines IA Kim, SS Bae, A Fernandes, JM Wu, RJ Muschel, WG McKenna, ... Cancer research 65 (17), 7902-7910, 2005 | 233 | 2005 |
| Synergistic Effect of the v-myc Oncogene with H-ras on Radioresistance WG McKenna, MC Weiss, B Endlich, CC Ling, VJ Bakanauskas, ... Cancer research 50 (1), 97-102, 1990 | 232 | 1990 |
| The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia TM Ashton, E Fokas, LA Kunz-Schughart, LK Folkes, S Anbalagan, ... Nature communications 7 (1), 12308, 2016 | 228 | 2016 |
